Impact of new treatment options for hepatitis C virus infection in liver transplantation
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of new treatment options for hepatitis C virus infection in liver transplantation
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 21, Issue 38, Pages 10760
Publisher
Baishideng Publishing Group Inc.
Online
2015-10-14
DOI
10.3748/wjg.v21.i38.10760
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation
- (2015) Teresa Maria Antonini et al. AIDS
- Drug Interactions With Direct-Acting Antivirals for Hepatitis C
- (2015) Sarah Burgess et al. ANNALS OF PHARMACOTHERAPY
- Efficacy of Ledipasvir and Sofosbuvir, With or Without Ribavirin, for 12 Weeks in Patients With HCV Genotype 3 or 6 Infection
- (2015) Edward J. Gane et al. GASTROENTEROLOGY
- Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation
- (2015) Michael Charlton et al. GASTROENTEROLOGY
- Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
- (2015) Michael Charlton et al. GASTROENTEROLOGY
- Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis
- (2015) Eric Lawitz et al. HEPATOLOGY
- Ledipasvir-sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimens
- (2015) David Wyles et al. HEPATOLOGY
- Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant
- (2015) Surakit Pungpapong et al. HEPATOLOGY
- Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation
- (2015) Xavier Forns et al. HEPATOLOGY
- Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection
- (2015) Anu Osinusi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Daclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated Cirrhosis
- (2015) Andrew J. Muir et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1
- (2015) Mark S. Sulkowski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 update
- (2015) Jose M. Miro et al. JOURNAL OF HEPATOLOGY
- Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study
- (2015) Lluis Castells et al. JOURNAL OF HEPATOLOGY
- EASL Recommendations on Treatment of Hepatitis C 2015
- (2015) JOURNAL OF HEPATOLOGY
- Superior outcomes in HIV–positive kidney transplant patients compared with HCV–infected or HIV/HCV–coinfected recipients
- (2015) Deirdre Sawinski et al. KIDNEY INTERNATIONAL
- Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial
- (2015) Mark Sulkowski et al. LANCET
- Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)
- (2015) Marc Bourlière et al. LANCET INFECTIOUS DISEASES
- Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipients
- (2015) Julio A. Gutierrez et al. LIVER TRANSPLANTATION
- Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: a report of three cases
- (2015) E. Righi et al. Transplant Infectious Disease
- Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease
- (2015) Elizabeth C. Verna et al. TRANSPLANTATION
- Re-treatment of Chronic Hepatitis C Virus Genotype 1 Infection After Relapse
- (2014) Anu Osinusi et al. ANNALS OF INTERNAL MEDICINE
- Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late
- (2014) Adriano M. Pellicelli et al. DIGESTIVE AND LIVER DISEASE
- Efficacy of new direct acting antivirals in transplant recipients and patients with advanced disease
- (2014) Sabela Lens et al. DIGESTIVE AND LIVER DISEASE
- Overall efficacy and safety results of sofosbuvir-based therapies in Phase II and III studies
- (2014) Alessandra Mangia et al. DIGESTIVE AND LIVER DISEASE
- ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection
- (2014) Pietro Andreone et al. GASTROENTEROLOGY
- Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
- (2014) Eric Lawitz et al. LANCET
- High post-transplant virological response in hepatitis C virus infected patients treated with pretransplant protease inhibitor-based triple therapy
- (2014) Elizabeth C. Verna et al. LIVER INTERNATIONAL
- An Interferon-free Antiviral Regimen for HCV after Liver Transplantation
- (2014) Paul Y. Kwo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
- (2014) Kris V. Kowdley et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
- (2014) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pros and cons of liver transplantation in human immunodeficiency virus infected recipients
- (2014) Umberto Baccarani WORLD JOURNAL OF GASTROENTEROLOGY
- Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics
- (2013) Anuoluwapo Osinusi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience
- (2013) Audrey Coilly et al. JOURNAL OF HEPATOLOGY
- Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin
- (2013) M. P. Manns et al. JOURNAL OF VIRAL HEPATITIS
- Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation
- (2013) Surakit Pungpapong et al. LIVER TRANSPLANTATION
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Feasibility of Telaprevir-Based Triple Therapy in Liver Transplant Patients with Hepatitis C Virus: SVR 24 Results
- (2013) Christoph R. Werner et al. PLoS One
- Genotype and Subtype Profiling of PSI-7977 as a Nucleotide Inhibitor of Hepatitis C Virus
- (2012) Angela M. Lam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Liver transplantation in the setting of chronic HCV
- (2012) Norah Terrault BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation
- (2012) Gregory T. Everson et al. HEPATOLOGY
- 1130 THE EFFECT OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS AND ANTIVIRAL ACTIVITY OF PSI-7977 IN HEPATITIS C INFECTED SUBJECTS TREATED FOR SEVEN DAYS
- (2012) E. Lawitz et al. JOURNAL OF HEPATOLOGY
- 202 USE OF TELAPREVIR PLUS PEG INTERFERON/RIBAVIRIN FOR NULL RESPONDERS POST OLT WITH ADVANCED FIBROSIS/CHOLESTATIC HEPATITIS C
- (2012) P. Kwo et al. JOURNAL OF HEPATOLOGY
- Projected future increase in aging hepatitis C virus-infected liver transplant candidates: A potential effect of hepatocellular carcinoma
- (2012) Scott W. Biggins et al. LIVER TRANSPLANTATION
- A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C
- (2011) Lisa I. Backus et al. Clinical Gastroenterology and Hepatology
- A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C
- (2011) Jules L. Dienstag et al. HEPATOLOGY
- An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
- (2011) Marc G. Ghany et al. HEPATOLOGY
- Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis c virus-coinfected liver transplant recipients: A FIPSE/GESIDA Prospective Cohort Study
- (2011) Asunción Moreno et al. LIVER TRANSPLANTATION
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection
- (2010) Michael R. Charlton et al. HEPATOLOGY
- Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus
- (2010) Michael J. Sofia et al. JOURNAL OF MEDICINAL CHEMISTRY
- Extrahepatic hepatitis C virus after transplantation: Diabetes and renal dysfunction
- (2010) Sabina Sabharwal et al. LIVER TRANSPLANTATION
- The natural history of recurrent hepatitis C and what influences this
- (2010) Edward J. Gane LIVER TRANSPLANTATION
- Individualized Extension of Pegylated Interferon Plus Ribavirin Therapy for Recurrent Hepatitis C Genotype 1b After Living-Donor Liver Transplantation
- (2010) Yoshihide Ueda et al. TRANSPLANTATION
- Insulin Resistance, Serum Adipokines and Risk of Fibrosis Progression in Patients Transplanted for Hepatitis C
- (2009) B. J. Veldt et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis
- (2009) Savino Bruno et al. HEPATOLOGY
- The global burden of hepatitis C
- (2009) Daniel Lavanchy LIVER INTERNATIONAL
- Natural history of postâliver transplantation hepatitis C: A review of factors that may influence its course
- (2009) Juan F. Gallegos-Orozco et al. LIVER TRANSPLANTATION
- The natural history of hepatitis C cirrhosis after liver transplantation
- (2009) Roberto J. Firpi et al. LIVER TRANSPLANTATION
- Pre-emptive antiviral therapy in living donor liver transplantation for hepatitis C: observation based on a single-center experience
- (2009) Sumihito Tamura et al. TRANSPLANT INTERNATIONAL
- Clinical Benefits of Antiviral Therapy in Patients with Recurrent Hepatitis C Following Liver Transplantation
- (2008) M. Berenguer et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Therapeutical Aspects and Outcome of HIV/HCV Coinfected Patients Treated with Pegylated Interferon plus Ribavirin in an Italian Cohort
- (2008) E. Righi et al. INFECTION
- Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study
- (2008) Jose A. Carrión et al. JOURNAL OF HEPATOLOGY
- The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation
- (2008) Ibrahim A. Hanouneh et al. LIVER TRANSPLANTATION
- Mortality related to chronic hepatitis B and chronic hepatitis C in France: Evidence for the role of HIV coinfection and alcohol consumption
- (2007) Patrick Marcellin et al. JOURNAL OF HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started